Navigation Links
Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings
Date:11/15/2012

GBI Research found that on average biobetter launches generate more revenues than their corresponding originator therapies. In some scenarios this extended to, the launch of a biobetter therapy substituting the sales from an existing originator product or biobetter therapy.

Scope

- Data and analysis on the impact of biobetter therapeutics on the major top selling biologics erythropoietin's, granulocyte-colony stimulating factors (G-CSF), interferon-?, interferon-beta, insulin and insulin analogs, human growth hormone and monoclonal and mAbs.- Pipeline analysis of biobetter therapies in major protein classes erythropoietin's, G-CSF, interferon-?, interferon-beta, insulin and insulin analogs, mAbs and TNF-?.- Key drivers and restraints that have had a significant impact on the market.- The competitive landscape of the global biobetter therapeutics market, including companies such as Celgene, Amgen, Bristol-Myers Squibb, Amylin and Dainippon Sumitomo Pharma.- Key M&A activities and licensing and co-development agreements that took place from 2010-2012 in the global Biobetters market.

Reasons to buy

- Align your product portfolio to the markets with high growth potential.- Develop business strategies by understanding the trends shaping and driving technological advancements in the field of biobetter therapies.- Identify key molecules in development being used for biobetter therapies. - Reinforce R&D pipelines by identifying common drug class biobetters in the pipeline for top selling protein classes.- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

Table of Contents

1 Table of Contents1 Table of Contents 61.1 List of Tables 81.2 List of Figures 82 Introduction 93 Global Market Overview 113.1 Biobetter Therapies Already on the Market 113.1.1 Erythropoietins 123.1.2 Granulocyte-colony Stimulating Factors 143.1.3 Interferon-?, Interferon-
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. AspenBio to Present at 2012 Lazard Capital Markets Healthcare Conference
2. Palatin Technologies, Inc. To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
3. Regulus to Present at the Lazard Capital Markets Healthcare Conference
4. PDL BioPharma to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
5. Tengion to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
6. Sangamo BioSciences Announces Presentation At The Lazard Capital Markets Healthcare Conference
7. MiMedx Group to Present at the BIOX; Noble Financial Capital Markets Life Sciences Exposition
8. Kinase Inhibitors: Global Markets -- Focus on the U.S.
9. MarketsandMarkets: Global Refurbished Medical Equipments Market worth $8.45 Billion by 2017
10. MarketsandMarkets: Global Spine Surgery Devices Market Worth $14.8 Billion by 2017
11. MarketsandMarkets: World Sensors Market in Healthcare Applications is expected to reach $13.11 billion by 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... A recent study from researchers in ... find that those who took probiotics were able to run ... study showed that in extreme heat conditions, probiotics were able ... acne treatment explains what this new discovery means ... their skin condition. , While researchers tote the benefits ...
(Date:5/21/2013)... 2013 First patients dosed with ... bromide designed using Prosonix, particle engineering platform ... of inhaled Respiratory Medicines by Design , has ... will assess its effect on lung function and the ... moderate to severe chronic obstructive pulmonary disease (COPD). The ...
(Date:5/21/2013)... Custom Learning Designs, Inc.(CLD) unveils the ... Tin Can API combined with its own proprietary ... leading developer of training content and solutions for ... , Tin Can API is a cost-effective learning ... more accurately measure the Return on Education (ROE) ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Alpha ... distributor , will be exhibiting for the 13th ... of Medical Instrumentation (AAMI) 2013 Conference and Expo. ... support, distribute, and manufacture healthcare technologies. This year’s ... Long Beach, California. , The three-day event ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2
... 2011 UV Flu Technologies, Inc. ( ... to announce it has expanded its International Distribution by adding ... its relationship with the Company,s Distributor in India, Ormed Systems, ... as well as other parts of the world. The Company ...
... Avaxia Biologics, Inc. , a privately-held biotech ... the gastrointestinal tract, announced today that the company completed ... A angel-led financing. Cherrystone Angels of Providence, Rhode Island ... and other undisclosed individuals. Mr. Robert Manning, the co-Chairman ...
... SQNM ), a life sciences company providing innovative ... Lazard Capital Markets 8th Annual Healthcare Conference at the Pierre ... Harry F. Hixson, Jr, Ph.D., Chairman and CEO, and Ronald ... will present on Tuesday, November 15, 2011 beginning at 8:30 ...
Cached Biology Technology:UV Flu Technologies Expands Its International Footprint 2UV Flu Technologies Expands Its International Footprint 3Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease 2Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference 2
(Date:5/22/2013)... Researchers working to improve durability in fuel cell ... University, have discovered links between electrode degradation processes ... quantifying the effects of electrode degradation stressors in ... membrane lifetime. , The findings of the study, ... the latest in a long-term study at Burnaby-based ...
(Date:5/22/2013)... drastically reduces the time and effort needed to ... biotechnology, scientists are reporting. Published in the journal ... the way for more rapid development of designer ... activities. , Keith Shearwin and colleagues explain that ... material DNA into a bacterium,s genome is critical ...
(Date:5/22/2013)... on how climate change will affect interactions between species ... Journal of Animal Ecology . This knowledge, they say, ... of how species are likely to be impacted by ... recognition among biologists that climate change is affecting how ... going to have very important consequences for the stability ...
Breaking Biology News(10 mins):Tests lead to doubling of fuel cell life 2UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5
... Carolina State University have found a specific gene in corn that ... diseases. In a paper ... Sciences , NC State plant pathologists and crop scientists pinpoint ... to Southern leaf blight, gray leaf spot and Northern leaf blight, ...
... use of biotechnology increases and more companies move ... to begin full-scale commercialization of seed mixtures in ... will become even more difficult. "Seed mixtures ... of larval behavior and greater adoption of insecticidal ...
... has for the first time found that female-to-male transsexual ... traits. , The Medical Research Council (MRC) funded ... and Developmental Disorders , has important implications for the ... persists into adulthood, and for the ,extreme male brain, ...
Cached Biology News:Study shows corn gene provides resistance to multiple diseases 2Seed mixtures and insurance pest management: Future norm in the Corn Belt? 2Female-to-male transsexual people have more autistic traits 2
... Error-free cloning of BAC (100+kb), fosmid ... Greater insert stability than any othe BAC ... for high yields and easy recombinant DNA ... or transcription-free (pSMART VC) vectors for the ...
Trop-2 Purified Anti-Human clone 162-46, Isotype Mouse IgG 1 , 100 µg Consult technical datasheet for details....
... BAC (100+kb), fosmid (40kb), and large plasmid ... any othe BAC vector. On command 20-50 ... easy recombinant DNA purification. Available with blue-white ... vectors for the highest insert stability. Kits ...
... Adapted to Sf-900 II ... isolated from Spodoptera frugiperda ... cells (1). The Sf21 ... serum-free suspension culture in ...
Biology Products: